Essa Pharma Inc Reports Results For The Quarter Ended In March: Earnings Summary

ESSA Pharma

06/05/2021 16:21

* ESSA Pharma Inc  EPIX.OQ  reported a quarterly adjusted loss
of 36 cents​​ per share for the quarter ended in March. The mean
expectation of five analysts for the quarter was for a loss
of 21 cents per share.
* Revenue was $0.00​​;  analysts expected $0.00.
* ESSA Pharma Inc's reported EPS for the quarter was a loss
of 36 cents​.
* The mean earnings estimate of analysts had fallen by
about 0.3% in the last three months.​ 
* In the last 30 days there have been no negative revisions of
earnings estimates and  
* ESSA Pharma Inc shares had risen by 4.2% this quarter and
gained 153.7% so far this year.
* The company reported a quarterly loss of $12.96 million.
* Wall Street's median 12-month price target for ESSA Pharma Inc
is $40.00 
* The current average analyst rating on the shares is "buy" and
the breakdown of recommendations is 5 "strong buy" or "buy," no
"hold" and no "sell" or "strong sell." 
This summary was machine generated May 6 at 03:21 p.m. GMT. ​All
figures in US Dollars.​